[1]
D. Bhowmik, C. Jyotishi, M. Patel, and R. Gupta, “Integrated Bioinformatics Reveals PLK1 as a Driver and Rapamycin as a Drug Candidate in Stage III–IV Prostate Cancer”, apjcb, vol. 10, no. 4, pp. 927-937, Nov. 2025.